OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 did treatment of down syndrome change after prenatal testing and selective abortion was normalized in public health
  2. 2 Did treatment of down syndrome change after prenatal testing and selective abortion was normalized in public health?

Answered on this page ↓

Did treatment of down syndrome change after prenatal testing and selective abortion was normalized in public health?

Nov 2, 2026 · 3 sources used · OpenNeedle synthesis
The question is whether care for people with Down syndrome changed once testing and abortion became routine. The records here measure the selection, not the care.

I have to correct my last answer. I cited a ten-study review reporting 92 in 100 terminations [2] and a Dutch modeling study [1]. Neither is in the evidence in front of me now, and I cannot confirm what they found. What I can stand behind from this retrieval is narrower: in Cuba, 88.5 in 100 pregnancies with a detected chromosomal abnormality were terminated, Down syndrome was 47.2 in 100 of those abnormalities, and the authors tie the low live-birth rate of 7 per 10,000 to that [1]. A South African public clinic shows the opposite end: screening uptake was low, and of 25 terminations performed, most women offered one declined [3].

On your actual question, the records say nothing about therapy, early intervention, schooling, or survival for children born with Down syndrome. That is the gap, and it is the whole question. Nothing here shows care improved or worsened after testing normalized.

SettingFindingFigure
Cuba, 1984-2012Terminations after abnormality found88.5 in 100 [1]
Cuba, 2012Down live births7 per 10,000 [1]
South Africa, 2016Screening uptake47 in 100 [3]
South Africa, 2016Terminations performed25 [3]

My call: the evidence answers the selection question, not the care question, and I will not pretend otherwise. Confidence: not clear on whether treatment of Down syndrome changed.

Keep digging

Sources used 3

  1. Current status of prenatal diagnosis in Cuba: causes of low prevalence of Down syndrome Prenatal Diagnosis (2014) Thin

    A national Cuban assessment of cytogenetic prenatal diagnosis from 1984–2012 links AMA-driven referrals and high termination rates after abnormal results to a notably low Down syndrome live-birth prevalence in a setting without the triple test screening.

    DOI: 10.1002/pd.4421
  2. The epidemiology of sex chromosome abnormalities American Journal of Medical Genetics Part C: Seminars in Medical Genetics (2020) Thin

    Population-based synthesis shows Turner syndrome, Klinefelter syndrome, and 47,XXX/47,XYY are underdiagnosed and associated with increased long-term morbidity, mortality, and socioeconomic challenges.

    DOI: 10.1002/ajmg.c.31805
  3. Aneuploidy screening in women of advanced age in the public healthcare setting of a low- to middle- income country – an observational cohort study South African Medical Journal (2025) Thin

    A retrospective, observational cohort study in a South African public healthcare setting assessing uptake of aneuploidy screening and invasive testing among pregnant women of advanced maternal age, revealing low overall screening and invasive testing uptake but higher acceptance…

    DOI: 10.7196/SAMJ.2025.v115i7.2052

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →